NCT06716775

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer: a Randomized, Controlled, Open-label Study.

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Jiangsu Healthy Life Innovation Medical Technology Co., Ltd · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized, controlled, open-label, phase III trials. The main purpose of this study is to evaluate the effectiveness and safety of tumor treating felds (TTF) combined with stereotactic radiosurgery (SRS) in the treatment of brain metastases from non-small cell lung cancer (NSCLC) .

Conditions

• NSCLC Brain Metastasis

Interventions

Type	Name	Description
DEVICE	Tumor treating felds (TTF)	Tumor Treating Fields will be administered continuously with a planned ≥ 18 h per day.
OTHER	Best Standard of Care	Patients will be treated with the best known standard of care for NSCLC brain metastasis and undergo SRS alone.

Timeline

• Start date: 2024-12-20
• Primary completion: 2028-06-30
• Completion: 2028-10-30
• First posted: 2024-12-04
• Last updated: 2024-12-04